Acute myeloid leukemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in those over 65. Around 150 people are diagnosed with the disease each year in ...

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers report. The aptamers -- short ...

When his father was diagnosed with leukaemia in 2025, a 10-year-old Malaysian boy stepped up to be his stem cell donor through a bone marrow transplant. It was the only way doctors said his father ...

A Central Square woman is turning one of her hardest battles of her life into a message of hope for others after being ...

LOS ANGELES (KTLA) — A 9-year-old boy from Los Angeles is being thanked for potentially saving his father’s life by donating stem cells to help treat his leukemia. Stephen Mondek is the youngest ...

LOS ANGELES -- A young boy from Southern California is being called a hero after he donated stem cells to save his father's life. Dr. Nick Mondek was at death's door until his son, Stephen, stepped in ...

Genome-wide chromatin accessibility profiling reveals how myelodysplastic syndrome (MDS) stem cells progressively lose normal stem-cell features and acquire myeloid progenitor-like characteristics.

Leukemic stem cells (LSCs) and stemness signatures contribute to minimal residual disease in patients with acute myeloid leukemia (AML), which is associated with an increased risk of relapse. The ...

Cancer stem cells are like zombies — even after a tumor is destroyed, they can keep coming back. These cells have an unlimited capacity to regenerate themselves, making more cancer stem cells and more ...

The impact of the use of hypomethylating agents prior to reduced intensity conditioning allogeneic bone marrow transplant among patients with MDS. This is an ASCO Meeting Abstract from the 2025 ASCO ...